Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health claims, device provisions in FDA reform bills cause for potential veto.

This article was originally published in The Tan Sheet

Executive Summary

HOUSE FDA REFORM BILL HEALTH CLAIMS PROVISIONS "UNDERCUT" NLEA, the Clinton Administration declares in a Nov. 4 letter addressing its concerns with the Senate and House versions of FDA reform legislation. Section 301 of the House bill would "undercut the Nutrition Labeling & Education Act of 1990 by permitting FDA to allow health or nutrient content claims without first obtaining public comment," the letter asserts. "This policy would undermine the provisions of the Administrative Procedures Act."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel